Document And Entity Information Statement [Table] Statement [Line Items] Statement Document Type Document Type Document Quarterly Report Document Period End Date Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Condensed Consolidated Balance Sheets Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable, net Inventory, Net Inventory Total inventory Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Restricted Cash, Noncurrent Restricted cash Operating Lease, Right-of-Use Asset Operating lease assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued expenses Operating Lease, Liability, Current Operating lease liabilities Liabilities, Current Total current liabilities Other Liabilities, Noncurrent [Abstract] Other liabilities: Operating Lease, Liability, Noncurrent Operating lease liabilities, net of current portion Derivative Liability, Noncurrent Derivative liability Contract with Customer, Liability, Noncurrent Deferred revenue Notes Payable, Noncurrent Notes payable, net Notes payable, noncurrent Other Liabilities, Noncurrent Other non-current liabilities Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 14) Equity, Attributable to Parent [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Common stock, $0.0001 par value; 400,000,000 and 400,000,000 shares authorized and 218,896,915 and 215,927,600 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity, Attributable to Parent Balance Balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Condensed Consolidated Statements of Operations and Comprehensive Loss Product and Service [Axis] Product and Service [Domain] Product [Member] Product revenue, net Collaboration Revenue means revenue derived from fees relating to Material Services performed by the Executive from Collaborations, net of payments to licensing agents but excluding fees paid to the Company related to licensing its trademarks or providing design services. Collaboration revenue Collaboration revenue Revenues [Abstract] Revenue: Revenue from Contract with Customer, Excluding Assessed Tax Total revenue, net Revenue Operating Expenses [Abstract] Costs and operating expenses: Cost of Goods and Services Sold Cost of product revenue Research and Development Expense Research and development Selling and Marketing Expense Selling and marketing General and Administrative Expense General and administrative Costs and Expenses Total costs and operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expense): Investment Income, Net Interest income Interest Expense, Nonoperating Interest expense Amount of increase (decrease) in the fair value of derivatives recognized in the income statement including accrued or paid royalty fees. Derivative, Gain (Loss) on Derivative and Other, Net Change in fair value of derivative liabilities Change in fair value of derivative liabilities Total Nonoperating Income (Expense) Total other income (expense), net Net loss Net loss attributable to common stockholders Earnings Per Share, Basic Net loss per share, basic (in dollars per share) Net loss per share - basic (in dollar per share) Weighted Average Number of Shares Outstanding, Basic Weighted average common shares outstanding, basic (in shares) Earnings Per Share, Diluted Net loss per share, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted Weighted average common shares outstanding, diluted (in shares) Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Amortization of Debt Issuance Costs Non-cash interest expense Depreciation, Depletion and Amortization Depreciation and amortization expense Depreciation Gain (Loss) on Disposition of Property Plant Equipment Loss on disposal of items of property and equipment Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable, net Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Inventories Inventory Increase (Decrease) in Accounts Payable Accounts payable The increase (decrease) during the reporting period in the aggregate amount of operating lease assets. Increase (Decrease) In Operating Lease Assets Operating lease assets Increase (Decrease) in Accrued Liabilities Accrued expenses Increase (Decrease) in Contract with Customer, Liability Deferred revenue Increase (Decrease) in Operating Lease Liability Operating lease liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Proceeds from Stock Options Exercised Proceeds from exercise of stock options Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Total cash, cash equivalents and restricted cash as shown on the statements of cash flows Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash investing and financing activities: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Change in right-of-use asset as a result of new, modified, and terminated leases Capital Expenditures Incurred but Not yet Paid Additions to property and equipment included in accounts payable and accrued expenses Condensed Consolidated Statements of Stockholders' Equity Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Increase (Decrease) in Stockholders' Equity [Roll Forward] Stockholders' Equity (Deficit) Shares, Outstanding Balance, shares Balance, shares Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon exercise of stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of common stock upon exercise of stock options, shares Value of stock issued during period related to the vesting of restricted stock units. Stock Issued During Period, Value, Restricted Stock Units Issuance of common stock upon vesting of restricted stock units The number of shares of stock issued during period related to the vesting of restricted stock units. Stock Issued During Period, Shares, Restricted Stock Units Issuance of common stock upon vesting of restricted stock units, shares Value of stock issued as a result of the exercise of warrants. Stock Issued During Period, Value, Warrants Exercised Issuance of common stock upon exercise of pre-funded warrants Shares of stock issued as a result of the exercise of warrants. Stock Issued During Period, Shares, Warrants Exercised Issuance of common stock upon exercise of pre-funded warrants, shares APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense Nature of the Business Nature of Operations [Table] Nature of Operations [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Nature of Operations [Line Items] Nature of the Business Business Description and Basis of Presentation [Text Block] Nature of the Business Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Licensing Agreements and Deferred Revenue [Abstract]. Licensing Agreements and Deferred Revenue The entire disclosure for licensing agreements and deferred revenue. Licensing Agreements and Deferred Revenue [Text Block] Licensing Agreements and Deferred Revenue Cash Equivalents and Restricted Cash. Cash and Cash Equivalents Disclosure [Text Block] Cash Equivalents and Restricted Cash Inventory Inventory Disclosure [Text Block] Inventory Expenses [Abstract] Accrued Expenses and Other Current Liabilities The entire disclosure for expenses, including accrued expenses. Expenses [Text Block] Accrued Expenses and Other Current Liabilities Financial Liabilities Debt Disclosure [Text Block] Financial Liabilities Derivative Liability. Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Liability Risks and Fair Value The entire disclosure for risks and fair value. Risks and Fair Value Disclosure [Text Block] Risks and Fair Value Equity Equity [Text Block] Equity Stock-Based Awards Share-Based Payment Arrangement [Text Block] Stock-Based Awards Net Loss Per Share Earnings Per Share [Text Block] Net Loss Per Share Segment Reporting Segment Reporting Disclosure [Text Block] Segment Reporting Commitments and Contingencies. Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Related Party Transactions Related Party Transaction [Table] Related Party Transaction [Line Items] Related Party Transactions Related Party Transactions Disclosure [Text Block] Related Party Transactions Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Use of Estimates, Policy [Policy Text Block] Use of Estimates Disclosure of accounting policy for unaudited interim financial information. Unaudited Interim Financial Information Policy [Policy Text Block] Unaudited Interim Financial Information New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued And Adopted Accounting Pronouncements Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Schedule of deferred revenue Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Schedule of reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheet to the total amounts shown in the statement of cash flows Schedule of Inventory, Current [Table Text Block] Schedule of components of inventory Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Schedule of Long-Term Debt Instruments [Table] Credit Facility [Axis] Credit Facility [Domain] Information pertaining to the Barings Credit Facility. Barings Credit Facility [Member] Barings Credit Facility Debt Instrument [Line Items] Financial Liabilities Derivative Liability Schedule of Debt [Table Text Block] Schedule of debt Schedule of Derivative Instruments [Table Text Block] Schedule of roll-forward of the derivative liability Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Financial Instrument [Axis] Financial Instruments [Domain] Represents information pertaining to royalty fee derivative liability. Royalty Fee Derivative Liability [Member] Royalty Fee Derivative Liability Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Derivative Liability Risks and Fair Value Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of concentration of credit risk and of significant suppliers and customers Derivative Instruments, Gain (Loss) [Table Text Block] Schedule of change in fair value of derivative liabilities Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of assets and liabilities measured at fair Value on recurring basis Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of main inputs to valuing the Derivative Liability Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of stock-based compensation expense related to stock options Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of basic and diluted net loss per share attributable to common stockholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of antidilutive securities, excluded from computation of diluted net loss per share Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of information about the Company's single segment Minimum liquidity amount required per the covenants of the credit agreement. Debt Instrument, covenants, Minimum Liquidity Requirement Minimum liquidity amount Debt Instrument, covenants, minimum liquidity requirement Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Information pertaining to a license agreement. License Agreement [Member] License Agreement Counterparty Name [Axis] Counterparty Name [Domain] Information pertaining to AffaMed Therapeutics Limited ("Affamed"). AffaMed [Member] AffaMed Incept. Incept [Member] Incept Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Licensing Agreements and Deferred Revenue The amount of royalties paid under the license agreement. Royalties Paid Royalties paid Change in Contract with Customer, Liability [Abstract] Total deferred revenue: Contract with Customer, Liability Deferred revenue, ending balance Deferred revenue, beginning balance Contract with Customer, Liability, Revenue Recognized Amounts recognized into revenue Restricted Cash and Cash Equivalents, Noncurrent Restricted cash (non-current) Cash and Cash Equivalent [Table] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Money Market Funds [Member] Money Market Funds Letter of Credit [Member] Letter of Credit Cash Equivalents and Restricted Cash Inventory, Raw Materials, Gross Raw materials Inventory, Work in Process, Gross Work-in-process Inventory, Finished Goods, Gross Finished goods Employee-related Liabilities, Current Accrued payroll and related expenses Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates and programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Rebates and Programs, Current Accrued rebates and programs Accrued Professional Fees, Current Accrued professional fees Carrying value as of the balance sheet date of obligations incurred through that date and payable for expenses related to research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Research And Development Expense Current Accrued research and development expenses Amount of accrued interest on notes payable. Accrued Interest, Notes Payable Accrued interest payable on Barings Credit Facility (Note 9) Other Accrued Liabilities, Current Accrued other Line of Credit Facility, Maximum Borrowing Capacity Borrowing capacity under the agreement Debt Instrument, Face Amount Principal amount of debt issued Proceeds from Issuance of Debt Proceeds from issuance of debt, net The interest rate floor. Debt Instrument, Interest Rate, Floor Interest rate floor (as a percent) Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] Debt Instrument, Basis Spread on Variable Rate Basis spread (as a percent) Royalty fees payable as percentage of net sales. Percentage of Royalty Fees Payable Royalty fees payable as percentage of net sales. Line of Credit Facility [Table] Line of Credit Facility [Line Items] Financial Liabilities Long-Term Debt, Gross Barings Credit Facility Debt Instrument, Unamortized Discount Less: unamortized discount Notes Payable Total Long-Term Debt, Maturity, Year Three Due for repayment in 2029 Derivative Instrument [Axis] Derivative Contract [Domain] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Derivative Liability Roll forward Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Ending Balance Beginning Balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Change in fair value Concentration Risk [Table] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Revenue from Contract with Customer, Product and Service Benchmark [Member] Total revenue Accounts Receivable [Member] Accounts receivable Concentration Risk Type [Axis] Concentration Risk Type [Domain] Customer Concentration Risk [Member] Customer Customer [Axis] Customer [Domain] Represents information pertaining to major customer one. Customer one [Member] Customer one Represents information pertaining to major customer two. Customer two [Member] Customer two Represents information pertaining to major customer three. Customer three [Member] Customer three Concentration Risk [Line Items] Concentration risk The total number of accredited financial institutions where the company has cash and cash equivalents balances, in amounts that exceed federally insured limits. Number Of Financial Institutions Number Of financial institutions Represents the number of major customers of the entity. Number Of Major Customers Number of major customers Concentration Risk, Percentage Concentration risk Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Line Items] Change in Fair Value of Derivative Liabilities Derivative, Gain (Loss) on Derivative, Net Change in fair value of derivative liability Royalty fee obligation, fees incurred. Royalty Fee Obligation Barings Royalty Fee Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Fair Value, Inputs, Level 3 [Member] Level 3 Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Recurring Basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets, Fair Value Disclosure [Abstract] Assets: Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Liabilities, Fair Value Disclosure [Abstract] Liability: Derivative Liability Derivative liability Derivative Liability, Statement of Financial Position [Extensible Enumeration] Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Also includes accrued interest. Notes Payable Including Accrued Interest Notes payable, amortized cost, including accrued interest Amount of accrued interest on debt. Debt Instrument Accrued Interest Accrued interest payable Debt Instrument, Fair Value Disclosure Estimated fair value Fair Value Measurement Inputs and Valuation Techniques [Table] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Price Volatility [Member] Revenue volatility Measurement Input, Discount Rate [Member] Revenue discount rate Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques Derivative Liability, Measurement Input Derivative Liability, Measurement Input Stock, Class of Stock [Table] Sale of Stock [Axis] Sale of Stock [Domain] Represents information related to the securities purchase agreement entered with certain institutional accredited investors. Securities Purchase Agreement [Member] Securities Purchase Agreement Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the member information pertaining to Pre-Funded Warrants. Pre-Funded Warrants [Member] Pre-Funded Warrants Class of Stock [Line Items] Equity Stock Issued During Period, Shares, New Issues Number of shares issued Shares Issued, Price Per Share Common stock, price per share Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of shares callable by warrants Represents the offering price for warrants issued. Warrants Issued, Offering Price Offering price of warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Weighted average exercise price to purchase common stock Class of Warrant or Right, Outstanding Warrants outstanding Warrant Exercised Warrant Exercised Warrants exercised Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Restricted Stock Units (RSUs) [Member] RSUs Restricted Stock Units (RSUs) Represents information pertaining to performance stock units (PSU). Performance Stock Units [Member] PSUs Performance Stock Units (PSUs) Represents information pertaining to performance options. Performance Options [Member] Performance options Plan Name [Axis] Plan Name [Domain] Represents the information pertaining to the 2021 Stock Incentive Plan. Two Thousand Twenty One Stock Incentive Plan [Member] 2021 Incentive Plan Represents the information pertaining to Inducement Stock Incentive Plan 2019. Inducement Stock Incentive Plan 2019 [Member] 2019 Inducement Plan Two Thousand Fourteen Employee Stock Purchase Plan [Member] Two Thousand Fourteen Employee Stock Purchase Plan [Member] 2014 Employee Stock Purchase Plan Vesting [Axis] Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] Tranche one Share-Based Payment Arrangement, Tranche Two [Member] Tranche two Share-Based Payment Arrangement, Tranche Three [Member] Tranche Three Represents fourth portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period. Share Based Compensation Award, Tranche Four [Member] Tranche four Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Stock-Based Awards Number of stock based compensation plans. Number of Stock Based Compensation Plans Number of stock based compensation plans Common Stock, Capital Shares Reserved for Future Issuance Common stock shares, reserved Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Shares issuable under options, granted (in shares) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted (in shares) Number of shares issuable upon exercise of equity instruments other than options. Share-Based Payment Arrangement, Number of Shares Upon Exercise of Equity Instruments Other Than Options Number of Common shares settleable upon vesting Represents the number of tranches under the share based payment arrangement. Share-Based Payment Arrangement, Number of Tranches Number of tranches Period over which stock price must meet specific targets for the awards to be earned under a share-based payment arrangement. This period is contingent on the satisfaction of performance conditions, such as achieving specific stock price hurdles. The format 'PnYnMnDTnHnMnS' can be used to represent this period, for example, 'P1Y5M13D' represents a reported fact of one year, five months, and thirteen days. Includes, but is not limited to, market conditions and performance targets. Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period Performance period (in years) Threshold consecutive trading days considered for the stock price trigger considered for the vesting conditions under the share based payment arrangement. Share Based Payment Arrangement, Threshold Consecutive Days Considered For The Stock Price Trigger Threshold days Represents the stock price trigger considered for the vesting under tranches in share based payment arrangements. Share Based Payment Arrangement, Stock Price Trigger For Vesting Trigger price Period over which additional service-based vesting conditions must be met for grants under a share-based payment arrangement. This period is contingent on the grantee's continued service with the company and is typically specified in 'PnYnMnDTnHnMnS' format, where 'P3Y' represents a reported fact of three years. Share Based Payment Arrangement With Additional Service Based Vesting Conditions For Grants, Period Period over which additional service-based vesting conditions (in Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Service period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Stock options expired or forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Unvested RSU's, Cancelled/forfeited (in shares) Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Research and Development Expense [Member] Research and development Selling and Marketing Expense [Member] Selling and marketing General and Administrative Expense [Member] General and administrative Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-Based Awards Share-Based Payment Arrangement, Expense Stock-based compensation expense Stock-based compensation Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized stock-based compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period of unrecognized stock-based compensation cost expected to be recognized Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Net Loss Per Share Earnings Per Share, Basic [Abstract] Basic net loss per share attributable to common stockholders Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Equity Option [Member] Options to purchase common stock Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net Loss Per Share Dilutive Securities, Effect on Basic Earnings Per Share Dilutive impact from potentially issuable common shares Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount, Net Total common stock equivalents Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] A single reportable segment. Single Reportable Segment [Member] Single reportable segment Segment Reporting Information [Line Items] Segment Reporting Number of Operating Segments Number of operating segments Number of Reportable Segments Number of reportable segments Research and Development Expense [Abstract] Research & Development Amount of expense for research and development related to Retina Programs, AXPAXLI for wet AMD. Research and Development Expense, Retina Program, One AXPAXLI Amount of expense for research and development related to other clinical and preclinical programs. Research and Development Expense, Other Clinical and Preclinical Programs Direct program expenses, Other clinical and preclinical programs Amount of expense for research and development related to unallocated expenses for personnel costs. Research and Development, Unallocated Expenses, Personnel Costs Unallocated expenses, Personnel costs Amount of expense for research and development related to unallocated expenses for all other costs. Research and Development, Unallocated Expenses, All Other Costs Unallocated expenses, All other costs The aggregate total amount of expenses directly related to the marketing or selling of products or services, excluding stock-based compensation and depreciation. Selling and Marketing Expense, Excluding Stock-Based Compensation and Depreciation Selling & Marketing The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line, excluding stock-based compensation and depreciation. General and Administrative Expense, Excluding Stock-Based Compensation and Depreciation General & Administrative Amount of expense for facilities. Facilities Expense Facilities Net amount of income (expense) related to nonoperating items not separately disclosed. Other Nonoperating Items Other non-operating items Loss Contingencies [Table] Litigation Status [Axis] Litigation Status [Domain] Pending Litigation [Member] EyePoint Litigation Loss Contingencies [Line Items] Commitments and Contingencies Loss Contingency Accrual Loss contingency accrual Represents information pertaining to Boston Image Reading Center LLC ("BIRC"). Boston Image Reading Center LLC [Member] BIRC Represents information pertaining to i2 Vision. i2 Vision Inc [Member] i2 Vision Inc Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Represents information pertaining to the Chief Medical Officer. Chief Medical Officer [Member] Chief Medical Officer Related Party [Member] Related Party Related Party Transaction, Amounts of Transaction Expenses (net credit) incurred Represents information pertaining to David Robinson. David Robinson [Member] David Robinson